期刊文献+

C-myc反义寡核苷酸抗恶性黑素瘤作用机制初探 被引量:1

Preliminary Study on the Mechanism of C-myc Antisense Oligodexynucleotide against Malignant Melanoma Cells
下载PDF
导出
摘要 目的 初步探讨C-myc反义寡核苷酸(ASODN)抗恶性黑素瘤可能作用机制。方法 以全硫代修饰的C myc反义寡核苷酸体外转染恶性黑素瘤细胞株A375,用台盼蓝活细胞计数法检测其对细胞增殖的影响,流式细胞仪检测细胞周期变化,间接免疫荧光流式细胞术检测HLA Ⅰ抗原的水平。结果 与对照组相比,①30μmol/LASODN组细胞生长明显受抑制,且发生G1 期阻滞;②ASODN组细胞上HLA Ⅰ抗原的水平明显上调。结论 C myc反义寡核苷酸可能通过抑制A375M细胞的增殖和上调HLA Ⅰ抗原水平的双重机制发挥抗肿瘤作用。 Objective To investigate the possible mechanism of c-myc antisense oligodexynucleotide (ASODN) against malignant melanoma cells.Methods C-myc ASODN was synthesized and transfected into melanoma cell line A375. The viability of the cells was determined by the trypanblue exclusion test.Cell cycle was determined by flow cytometry.HLA-Ⅰexpression was examined by indirect immunofluorescence flow cytometry. Results The proliferation of A375 cells exposed to 30 μmol/L ASODN was decreased as compared to control group and SODN group.Cell cycles were blocked in G 1stage.The expression of HLA-Ⅰantigen was up-regulated by ASODN.Conclusion The inhibitory effect on malignant melanoma cells may be performed by the antiproliferation of c-myc ASODN and the up-regulation of HLA-Ⅰexpression by c-myc ASODN.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2005年第1期3-5,共3页 The Chinese Journal of Dermatovenereology
关键词 原癌基因 寡核苷酸 反义 黑素瘤 组织相容性抗原Ⅰ类 Protooncogene Oligonucleotides,antisense Melanoma Histocompatibility antigens class I
  • 相关文献

参考文献9

  • 1刘新,王梦华.肿瘤的HLA表达及其临床意义[J].微生物学杂志,2003,23(3):48-49. 被引量:4
  • 2Chana JS,Grover R,Tulley P,et al. The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma[J]. Br J Plast Surg,2002, 55(8) : 623-627.
  • 3Stewart DA, Xu X,Thomas SD,et al.Acridine-modified,clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression[J]. Nucleic Acids Res,2002, 30(11) : 2565-2574.
  • 4Peltenburg LT,Schrier PI.Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements[J].Immunogenetics,1994,40:54-61.
  • 5Heikkila R,Schwab G,Wickstrom E,et al.A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1[J].Nature,1987,328:445-449.
  • 6Biroccio A,Amodei S,Antonelli A,et al.Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis[J].J Biol Chem,2003, 278(37) : 35693-35701.
  • 7Griffioen M,Steegenga WT,Ouwerkerk IJ,et al.Repression of the minimal HLA-B promoter by c-myc and p53 occurs through independent mechanisms[J].Mol Immunol,1998,35(13):829-835.
  • 8Inghirami G,Grignani F,Sternas L,et al.Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human Blymphoblastoid cells[J]. Science,1990,250:682-686.
  • 9Peltenburg LT,Schrier PI.Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements[J]. Immunogenetics,1994,40:54-61.

二级参考文献10

  • 1Tamura M, Nishizaka S, Maeda Y, et al. Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes[J]. Jpn J Cancer Res,2001 Jul; 92(7):762~7.
  • 2Zambon A, Mandruzzato S, Parenti A, et al. MAGE, BAGE and GAGE geue expression in patients with esophageal aquamous cell carcinoma and adenocarcinoma of the gastic cardia[J]. Cancer,2001 May 15; 91(10): 1882~8.
  • 3Lanier LL, Corliss BC, WUJ Leong, et al.[J].cell, 1998,92: 705.
  • 4Yamaguchi Y, Ohta K, Shimizu K, et al. Generation of cyto toxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2 [ J ]. Anticancer Res,2001 Jan-Feb; 21(1B): 669~77.
  • 5Garrido F, Fentenstein H, et al.[J].Nature, 1996,251:705~7.
  • 6Ishigami S, Natsugoe S, Tokuda K, et al. Invatriant chain expression in gastic cancer[J]. Cancer Lett. 2001 Jul 10; 168(1):87~91.
  • 7王毅鑫,阮灿平,李莉,施靖华,孔宪涛.消化系肿瘤患者手术前后CD16及T细胞活化抗原表达变化的临床意义[J].实用肿瘤杂志,1998,13(4):211-213. 被引量:2
  • 8程伏林,杨国梁,李培云,唐芝姣.乳腺癌HLA-DR表达及其临床价值[J].实用肿瘤杂志,1998,13(4):208-211. 被引量:2
  • 9白明,金阳,陶晓南,李元桂,辛建保.肺癌患者肺泡巨噬细胞上HLA-Ⅱ类抗原的表达[J].同济医科大学学报,1998,27(6):481-483. 被引量:2
  • 10赵亮.HLA表型与肿瘤逃逸[J].国外医学(免疫学分册),2001,24(1):4-7. 被引量:10

共引文献3

同被引文献7

  • 1邓超,包菊平.反义寡核苷酸技术的进展及在医学中的应用[J].海南医学院学报,2003,9(6):375-377. 被引量:2
  • 2Grover R, Pacifico MD, Wilson GD, et al. Use of oncogene expression as an independent prognostic marker for primary melanoma [ J ]. Ann Plast Surg,2003,50(2): 183 - 187.
  • 3Kraehn GM, Utikal J, Udart M, et al. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases[ J].Br J Cancer,2001,84( 1 ) :72 -79.
  • 4Chana JS,Grover R,Tulley P,et al. The c-myc oncogen e:use of a biological prognostic marker as a potential target for gene therapy in melanoma [J]. Br J Plast Surg,2002,55(8) :623 -627.
  • 5Stewart DA, Xu X, Thomas SD, et al. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-myc expression and B16-F0 tumor progression [ J]. Nucleic Acids Res,2002,30( 11 ) :2565 -2574.
  • 6Heikkila R, Schwab G, Wickstrom E, et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1[J]. Nature,1987,328 (6129) :445 -449.
  • 7李红玲,孙秉中,王慧.survivin反义寡核苷酸诱导淋巴瘤细胞凋亡及对化疗药的增敏作用[J].中华血液学杂志,2004,25(4):223-226. 被引量:10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部